MX2017012877A - Composiciones gomosas de multicomponentes con nucleo suave. - Google Patents

Composiciones gomosas de multicomponentes con nucleo suave.

Info

Publication number
MX2017012877A
MX2017012877A MX2017012877A MX2017012877A MX2017012877A MX 2017012877 A MX2017012877 A MX 2017012877A MX 2017012877 A MX2017012877 A MX 2017012877A MX 2017012877 A MX2017012877 A MX 2017012877A MX 2017012877 A MX2017012877 A MX 2017012877A
Authority
MX
Mexico
Prior art keywords
composition
multicomponent
gummy
soft core
dosage forms
Prior art date
Application number
MX2017012877A
Other languages
English (en)
Other versions
MX394829B (es
Inventor
Romanoschi Ovidiu
Oryniak Caryn
C Muniz Luis
Bagley Lindsey
Godfrey Graham
Huatan Hiep
Original Assignee
Church & Dwight Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Church & Dwight Co Inc filed Critical Church & Dwight Co Inc
Publication of MX2017012877A publication Critical patent/MX2017012877A/es
Publication of MX394829B publication Critical patent/MX394829B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/50—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by shape, structure or physical form, e.g. products with supported structure
    • A23G3/54—Composite products, e.g. layered, coated, filled
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Confectionery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente descripción de la invención se refiere a formas de dosificación masticables orales que son adecuadas para la administración de uno o más ingredientes activos a un consumidor, particularmente, a un individuo humano. Las formas de dosificación pueden configurarse como composiciones de multicomponentes formadas de un primer componente que incluye una composición gomosa, al menos un componente adicional que incluye una composición que es diferente de la composición gomos, y un ingrediente activo. La composición gomosa y la segunda composición pueden ser co-depositadas para formar una forma de dosificación de multicomponentes en donde la cubierta gomosa rodea al menos parcialmente un núcleo que es sólido o lí­quido a temperatura estándar.
MX2017012877A 2015-04-07 2016-04-06 Composiciones gomosas de multicomponentes con nucleo suave. MX394829B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562144224P 2015-04-07 2015-04-07
US201562238947P 2015-10-08 2015-10-08
PCT/US2016/026228 WO2016164470A1 (en) 2015-04-07 2016-04-06 Multicomponent gummy compositions with soft core

Publications (2)

Publication Number Publication Date
MX2017012877A true MX2017012877A (es) 2018-07-06
MX394829B MX394829B (es) 2025-03-24

Family

ID=57072920

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2017012878A MX395710B (es) 2015-04-07 2016-04-06 Composiciones gomosas de multicomponentes con nucleo duro.
MX2017012877A MX394829B (es) 2015-04-07 2016-04-06 Composiciones gomosas de multicomponentes con nucleo suave.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2017012878A MX395710B (es) 2015-04-07 2016-04-06 Composiciones gomosas de multicomponentes con nucleo duro.

Country Status (8)

Country Link
US (3) US11154495B2 (es)
EP (2) EP3280370A4 (es)
CN (2) CN107613918B (es)
AU (2) AU2016246580B2 (es)
CA (2) CA2981759C (es)
ES (1) ES2968450T3 (es)
MX (2) MX395710B (es)
WO (2) WO2016164470A1 (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018160295A1 (en) * 2017-01-25 2018-09-07 Yiannios James John Dietary supplement compositions with enhanced delivery matrix, gummies, chocolates, atomizers and powders containing same, and methods of making same
US10206572B1 (en) 2017-10-10 2019-02-19 Carrot, Inc. Systems and methods for quantification of, and prediction of smoking behavior
WO2016164470A1 (en) * 2015-04-07 2016-10-13 Church & Dwight Co., Inc. Multicomponent gummy compositions with soft core
US20170340000A1 (en) * 2016-05-31 2017-11-30 William Willard Drink container delivery system
US10960076B2 (en) 2017-01-25 2021-03-30 Church & Dwight Co. Inc. Gummy dosage forms comprising serine
WO2018160840A1 (en) * 2017-03-01 2018-09-07 Church & Dwight Co., Inc. Gummy composition with improved stability
AU2018239993B2 (en) * 2017-03-20 2024-01-25 Bayer Healthcare Llc Chewable gel products for active pharmaceutical ingredients
CN112312915A (zh) * 2018-06-11 2021-02-02 西雅图咖米公司 低血糖胶粘组合物及其制备和使用方法
US12390416B2 (en) 2018-07-18 2025-08-19 USpharma Ltd Chewable pharmaceutical dosage forms
US11273123B2 (en) 2018-07-18 2022-03-15 USpharma Ltd Chewable pharmaceutical dosage forms
IL262768B (en) 2018-11-04 2020-08-31 Ambrosia Supherb Ltd A chewable tablet and method of preparing the same
CN110046697A (zh) * 2019-04-26 2019-07-23 北京理工大学 一种基于K指数的Kp指数现报方法
IT201900006491A1 (it) * 2019-05-02 2020-11-02 Pnk Farm Srl Forme farmaceutiche o nutraceutiche funzionalizzate
US12433321B2 (en) 2019-12-09 2025-10-07 Nicoventures Trading Limited Oral composition with beet material
US12439949B2 (en) 2019-12-09 2025-10-14 Nicoventures Trading Limited Oral compositions with reduced water activity
US11969502B2 (en) 2019-12-09 2024-04-30 Nicoventures Trading Limited Oral products
US11826462B2 (en) 2019-12-09 2023-11-28 Nicoventures Trading Limited Oral product with sustained flavor release
US11872231B2 (en) 2019-12-09 2024-01-16 Nicoventures Trading Limited Moist oral product comprising an active ingredient
US11617744B2 (en) 2019-12-09 2023-04-04 Nico Ventures Trading Limited Moist oral compositions
US11793230B2 (en) 2019-12-09 2023-10-24 Nicoventures Trading Limited Oral products with improved binding of active ingredients
US12310959B2 (en) * 2019-12-09 2025-05-27 Nicoventures Trading Limited Oral compositions with reduced water content
US12439952B2 (en) 2019-12-09 2025-10-14 Nicoventures Trading Limited Moist oral compositions
US12520867B2 (en) 2019-12-09 2026-01-13 Nicoventures Trading Limited Buffered oral compositions
CN115151144A (zh) 2020-02-20 2022-10-04 汤普高姆工业有限公司 没有添加的糖的基于植物的即食凝胶产品及其在剂的递送中的用途
US20220062350A1 (en) * 2020-09-03 2022-03-03 Pharmavite Llc Oil-in-water emulsion gummy composition
EP4255399A4 (en) * 2020-12-01 2024-12-18 Seattle Gummy Company Ped5 inhibitor semi-solid compositions and methods of making and using thereof
WO2022190042A1 (en) * 2021-03-12 2022-09-15 Nicoventures Trading Limited Oral products with self-emulsifying system
US12514844B1 (en) * 2021-04-05 2026-01-06 Lock Box LLC Cannabinoid compositions and dosage forms
US20230000764A1 (en) * 2021-06-11 2023-01-05 Boa Nutrition, Inc. Pressurized nutritional supplement delivery
WO2022266523A1 (en) * 2021-06-18 2022-12-22 Seattle Gummy Company Chewable gel compositions with extended oral resident time and methods of making and using thereof
MX2023015529A (es) 2021-06-25 2024-03-05 Nicoventures Trading Ltd Productos orales y metodo de fabricacion.
CA3233283A1 (en) 2021-09-14 2023-03-23 Transport Authority, Inc. Systems and methods for accurate and repeatable delivery of active pharmaceutical ingredients
US12053484B2 (en) 2021-10-29 2024-08-06 Medicated Chews, Llc Simethicone chewable composition
WO2023158816A1 (en) * 2022-02-18 2023-08-24 Transport Authority, Inc. Layered edible product for multi-stage dosing of multi-function active pharmaceutical ingredients
WO2023172508A1 (en) * 2022-03-09 2023-09-14 Isp Investments Llc Co-processed excipient composition
US12016359B2 (en) 2022-11-11 2024-06-25 Pharmavite Llc Oil-in-water emulsion gummy composition with water soluble active ingredient(s)
BE1031104B1 (nl) * 2022-12-05 2024-07-01 Cosmotrend Bv Werkwijze en systeem voor het maken van gummy consumptieartikelen omvattende functionele ingrediënten
US20240188583A1 (en) * 2022-12-07 2024-06-13 Santiago Martinez Torres Filled gummies and formulations thereof
WO2025003623A1 (en) 2023-06-29 2025-01-02 Mccullagh Rose Lindsay Delivery of pharmaceuticals or nutritional supplements
CN116918895B (zh) * 2023-07-20 2024-08-09 宁波吉典健康科技有限公司 一种含高负载量液体胶囊的营养软糖的制备方法
WO2026015433A1 (en) * 2024-07-08 2026-01-15 Bayer Healthcare Llc In situ preparation of gummy compositions in blister
US12599569B1 (en) * 2024-12-30 2026-04-14 King Saud University Encapsulated resveratrol (RSV) nanoparticles

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004595A (en) 1986-12-23 1991-04-02 Warner-Lambert Company Multiple encapsulated flavor delivery system and method of preparation
US6056992A (en) 1988-06-02 2000-05-02 Campbell Soup Company Encapsulated additives
US5759599A (en) 1992-03-30 1998-06-02 Givaudan Roure Flavors Corporation Method of flavoring and mechanically processing foods with polymer encapsulated flavor oils
US5690990A (en) 1994-03-04 1997-11-25 Arnhem, Inc. Process for encapsulating the flavor with colloid gel matrix
US6117455A (en) 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
EP0936877B1 (en) 1996-10-09 2003-11-26 Givaudan SA Process for preparing beads as food additive
WO1998020860A2 (en) 1996-11-15 1998-05-22 Fmc Corporation Hydrocolloid delivery system
US6039901A (en) 1997-01-31 2000-03-21 Givaudan Roure Flavors Corporation Enzymatically protein encapsulating oil particles by complex coacervation
US6045835A (en) 1997-10-08 2000-04-04 Givaudan Roure (International) Sa Method of encapsulating flavors and fragrances by controlled water transport into microcapsules
US6106875A (en) 1997-10-08 2000-08-22 Givaudan Roure (International) Sa Method of encapsulating flavors and fragrances by controlled water transport into microcapsules
US6292814B1 (en) 1998-06-26 2001-09-18 Hitachi America, Ltd. Methods and apparatus for implementing a sign function
US6060078A (en) 1998-09-28 2000-05-09 Sae Han Pharm Co., Ltd. Chewable tablet and process for preparation thereof
PL347581A1 (en) 1998-11-13 2002-04-08 Warner Lambert Co Non-stick soft confectionery composition and methods of making the same
NO329694B1 (no) * 1999-04-13 2010-12-06 Beecham Pharm Pte Ltd Farmasoytisk formulering og anvendelse derav, samt belagt tablett
EP1176874A1 (en) 1999-05-12 2002-02-06 CP Kelco ApS Food composition with high solids content, a method for its preparation as well as the use of carrageenans for gelling a food composition
ZA200003120B (en) 1999-06-30 2001-01-02 Givaudan Roure Int Encapsulation of active ingredients.
EP1136067A1 (en) 2000-03-23 2001-09-26 Pfizer Limited Oral formulations of medicaments
GB2367736A (en) * 2000-10-10 2002-04-17 Nestle Sa Water-based hydrocolloid casing
US6602518B2 (en) 2001-06-28 2003-08-05 Wm. Wrigley Jr. Company Chewable product including active ingredient
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
ES2302926T5 (es) 2002-04-25 2012-08-23 Banner Pharmacaps, Inc. Cápsula blanda masticable
WO2005011402A1 (ja) 2003-07-31 2005-02-10 Morinaga Milk Industry Co., Ltd. 咀嚼性カプセル及びその製造方法
US20050260329A1 (en) * 2004-05-18 2005-11-24 Christianita Yusuf Production of liquid center filled confections
US20060263475A1 (en) * 2004-08-25 2006-11-23 Cadbury Adams Usa, Llc. Center-filled chewing gum composition
US9271817B2 (en) 2005-07-05 2016-03-01 Cook Biotech Incorporated Tissue augmentation devices and methods
US20070141198A1 (en) * 2005-12-21 2007-06-21 Marguerite Yang Multilayered confectionery products and methods regarding same
US20080063748A1 (en) 2006-09-08 2008-03-13 Cadbury Adams Usa Llc. Center-fill confectionery and chewing gum compositions containing suspended saccharide particles
WO2008067037A2 (en) 2006-10-05 2008-06-05 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
WO2008079927A1 (en) * 2006-12-21 2008-07-03 Wm. Wrigley Jr. Company Center-filled confectionery products
AU2007353824A1 (en) 2007-04-06 2008-11-27 Source Precision Medicine, Inc. Gene expression profiling for identification, monitoring, and treatment of cervical cancer
EP2164346A1 (en) * 2007-04-09 2010-03-24 Cadbury Adams USA LLC Edible products for treatment of nasal passages
JP2010529073A (ja) 2007-06-06 2010-08-26 ビーエーエスエフ ソシエタス・ヨーロピア チュアブル錠及びトローチ剤製造のための医薬製剤
US8404275B2 (en) * 2007-07-01 2013-03-26 Vitalis Llc Combination tablet with chewable outer layer
WO2009007769A1 (en) 2007-07-06 2009-01-15 Gumlink A/S Multi-modular chewing gum tablet
US20100003390A1 (en) 2008-07-03 2010-01-07 Avid Health, Inc. Method for adding functional components to hydrocolloid bases that require cooking
CN102112114A (zh) * 2008-08-08 2011-06-29 麦克内尔-Ppc股份有限公司 使用三氯蔗糖作为制粒剂
US20100226904A1 (en) 2009-03-05 2010-09-09 Hero Nutritionals, LLC Organic chewable supplement
US20100330058A1 (en) 2009-06-24 2010-12-30 Hero Nutritionals, LLC Chewable drug
CA2706272C (en) * 2010-06-03 2020-05-05 Accucaps Industries Limited Multi phase soft gel capsules, apparatus and method thereof
US20120035277A1 (en) 2010-08-04 2012-02-09 Hero Nutritionals, LLC Liquid-filled chewable supplement
WO2012106582A2 (en) * 2011-02-03 2012-08-09 Snap Infusion Llc Confection composition
EP2500016A1 (en) 2011-03-18 2012-09-19 Laboratorios Del. Dr. Esteve, S.A. Doxylamine resinate complex
CN102813275B (zh) * 2011-06-10 2015-09-30 杭州养生堂保健品有限公司 一种咀嚼型软胶囊皮和咀嚼型软胶囊
US9763928B2 (en) * 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US20150030718A1 (en) 2012-03-12 2015-01-29 Aker Biomarine Antarctic As Oxidixable fatty acid composition delivery form
US20130287899A1 (en) 2012-04-25 2013-10-31 Avid Health, Inc. Center-in-shell chewable compositions with functional components
US20130316053A1 (en) * 2012-05-25 2013-11-28 Martin Rifkin Methods of making center-in-shell chewable compositions with functional components
US20160045433A1 (en) 2014-08-13 2016-02-18 Debbie Whitney Children's Medication Delivery Device
WO2016164470A1 (en) * 2015-04-07 2016-10-13 Church & Dwight Co., Inc. Multicomponent gummy compositions with soft core

Also Published As

Publication number Publication date
US11154495B2 (en) 2021-10-26
US10328023B2 (en) 2019-06-25
EP3280273B1 (en) 2023-10-18
US20160296470A1 (en) 2016-10-13
CA2981752A1 (en) 2016-10-13
CN107613918B (zh) 2021-03-09
ES2968450T3 (es) 2024-05-09
MX2017012878A (es) 2018-08-15
WO2016164470A1 (en) 2016-10-13
CN107613918A (zh) 2018-01-19
AU2016246583B2 (en) 2020-06-25
EP3280273A1 (en) 2018-02-14
MX394829B (es) 2025-03-24
CA2981759A1 (en) 2016-10-13
CA2981759C (en) 2021-10-12
AU2016246580B2 (en) 2020-12-17
WO2016164464A1 (en) 2016-10-13
US20200000716A1 (en) 2020-01-02
US20160296474A1 (en) 2016-10-13
EP3280370A4 (en) 2019-01-02
AU2016246583A1 (en) 2017-10-26
US10786447B2 (en) 2020-09-29
EP3280273A4 (en) 2018-11-14
AU2016246580A1 (en) 2017-10-26
CN107613789A (zh) 2018-01-19
MX395710B (es) 2025-03-25
CA2981752C (en) 2020-08-25
EP3280370A1 (en) 2018-02-14

Similar Documents

Publication Publication Date Title
MX2017012877A (es) Composiciones gomosas de multicomponentes con nucleo suave.
UY36665A (es) Derivados de ciclohexano sustituidos con amidas
DOP2017000137A (es) Benzamidas sustituidas con 1,3–tiazol–2–ilo.
UY34701A (es) Formas sólidas de un profármaco de nucleótidos de tiofosforamidato
CR20190212A (es) 1,2,4-triazolonas 2,4,5-trisustituidas
BR112018076283A2 (pt) métodos e composições para potencializar terapias de célula tronco
ECSP11010869A (es) Combinación farmacéutica 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol y un antiepiléptico
MX378386B (es) Composiciones antiirritantes sinérgicas de taurina y aloe.
BR112012019997A2 (pt) composições de cuidado oral
DOP2014000300A (es) Composiciones farmacéuticas y tratamiento de mastitis
UY37971A (es) Derivados de indol macrocíclicos sustituidos
MX2017007184A (es) Composicion a base de aminoacidos para recuperacion de fibroelastina en tejidos conectivos dermicos.
CO2019011547A2 (es) Compuesto sólido cristalino novedoso de clorhidrato de 3-fenil-4-propil-1-(piridin-2-il)-1h-pirazol-5-ol
DOP2016000007A (es) Pirazolpiridinas sustituidas
CR20160235A (es) Tienopirimidinas como inhibidores mknk1 y mknk2
CR20170142A (es) Composiciones farmacéuticas resistentes al abuso
WO2014147182A3 (en) Substituted n-biphenyl-3-acetylamino-benzamides and n-[3-(acetylamino)phenyl]-biphenyl-carboxamides and their use as inhibitors of the wnt signalling pathway
MX2018004304A (es) DERIVADOS DE QUINOXALINA Y PIRIDOPRAZINA COMO INHIBIDORES DE PI3Kß.
AR086395A1 (es) Envase para el tratamiento de patologias
CO2019006652A2 (es) Amidas aromáticas de ácidos carboxílicos como antagonistas del receptor de bradiquinina b1
MX2020005564A (es) Sales de 4-amino-n-(1-((3-cloro-2-fluorofnil)amino)-6-metilisoquin olin-5-il)tieno[3,2-d]pirimidino-7-carboxamida, y formas cristalinas de las mismas.
MX2022006979A (es) Productos orales con liberacion controlada.
CO2018002428A2 (es) Amida seleccionada de ácido gamma-hidroxiburico y usos de la misma en el tratamiento de abuso de alcohol
MX2018012998A (es) Uso de amino azucar como plastificante.
CO2017001076A2 (es) Composiciones farmacéuticas antihiperalgésicas, antialodínicas y antiinflamatorias que contienen pregabalina y meloxicam